BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24311644)

  • 1. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
    Rossetti AO; Jeckelmann S; Novy J; Roth P; Weller M; Stupp R
    Neuro Oncol; 2014 Apr; 16(4):584-8. PubMed ID: 24311644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors.
    Swisher CB; Doreswamy M; Gingrich KJ; Vredenburgh JJ; Kolls BJ
    Neurocrit Care; 2012 Feb; 16(1):109-13. PubMed ID: 21882056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the cost-effectiveness of treatment for refractory partial epilepsy: a simulation model for pregabalin and levetiracetam].
    Díaz S; Argumosa A; Horga de la Parte JF; Vera-Llonch M; Dukes E; Rejas-Gutiérrez J
    Rev Neurol; 2007 Oct 16-31; 45(8):460-7. PubMed ID: 17948211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
    Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ
    Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study.
    Ciesielski AS; Samson S; Steinhoff BJ
    Epilepsy Behav; 2006 Nov; 9(3):424-31. PubMed ID: 16949344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam monotherapy--outcomes from an epilepsy clinic.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life.
    Maschio M; Dinapoli L; Sperati F; Pace A; Fabi A; Vidiri A; Muti P
    J Neurooncol; 2011 Aug; 104(1):205-14. PubMed ID: 21107994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
    Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
    BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
    Maschio M; Dinapoli L; Sperati F; Pace A; Fabi A; Vidiri A; Pompili A; Carapella CM
    Epileptic Disord; 2012 Dec; 14(4):388-97. PubMed ID: 23248037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam therapy in patients with brain tumour and epilepsy.
    Maschio M; Albani F; Baruzzi A; Zarabla A; Dinapoli L; Pace A; Pompili A; Carapella CM; Occhipinti E; Jandolo B
    J Neurooncol; 2006 Oct; 80(1):97-100. PubMed ID: 16685465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
    Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW
    J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygonogram and isobolographic analysis of interactions between various novel antiepileptic drugs in the 6-Hz corneal stimulation-induced seizure model in mice.
    Luszczki JJ; Panasiuk A; Zagaja M; Karwan S; Bojar H; Plewa Z; Florek-Łuszczki M
    PLoS One; 2020; 15(6):e0234070. PubMed ID: 32479532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam monotherapy for elderly patients with epilepsy.
    Alsaadi TM; Koopmans S; Apperson M; Farias S
    Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study.
    Rosenow F; Schade-Brittinger C; Burchardi N; Bauer S; Klein KM; Weber Y; Lerche H; Evers S; Kovac S; Hallmeyer-Elgner S; Winkler G; Springub J; Niedhammer M; Roth E; Eisensehr I; Berrouschot J; Arnold S; Schröder M; Beige A; Oertel WH; Strzelczyk A; Haag A; Reif PS; Hamer HM;
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1093-8. PubMed ID: 22595362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Kutlu G; Gomceli YB; Unal Y; Inan LE
    Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
    Ben-Menachem E; Falter U
    Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.
    Newton HB; Dalton J; Goldlust S; Pearl D
    J Neurooncol; 2007 Sep; 84(3):293-6. PubMed ID: 17431542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin in patients with primary brain tumors and seizures: a preliminary observation.
    Novy J; Stupp R; Rossetti AO
    Clin Neurol Neurosurg; 2009 Feb; 111(2):171-3. PubMed ID: 18977587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.